Ely Lilly to spend billions on new pharmaceutical manufacturing sites
Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the United States and make the nation the world's leader in pharmaceutical production.
Lilly to Spend $27 Billion to Bolster US Drug Manufacturing
Eli Lilly & Co. will spend at least $27 billion to build four US manufacturing plants, the latest company to brace for the potential impact of President Donald Trump’s tariffs.
Eli Lilly to spend $27B on four new manufacturing sites
Indianapolis-based pharmaceutical giant Eli Lilly and Co. announced plans Wednesday to add four new manufacturing sites in a roughly $27 billion investment expected to create 3,000 jobs and nearly 10,000 construction positions during the buildout.
Eli Lilly will build 4 new manufacturing sites to increase domestic drug production
Eli Lilly and Co. is in negotiations with several states and plans to announce the locations of four new manufacturing plants later this year.
Eli Lilly says it will spend billions to move drug manufacturing to U.S. soil
Eli Lilly said it plans to build three new plants in the United States to make the key ingredients used in pharmaceuticals, part of a doubling of its investment in manufacturing.
Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffs
Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the United States, shoring up domestic manufacturing as President Donald Trump threatens new tariffs on pharmaceuticals.
Eli Lilly to spend $27 billion to bolster U.S. drug manufacturing as Trump tariffs loom
The push to onshore manufacturing was already underway at Lilly, which has been investing heavily to boost production capacity for Zepbound and Mounjaro.
Eli Lilly unveils $27bn US investment as corporate America seeks to woo Trump
Eli Lilly has unveiled a $27bn investment in US manufacturing facilities as the pharmaceutical industry prepares for the threat of tariffs and mounts a charm offensive aimed at President Donald Trump’s new administration.
Five Years Since Covid Wreckage Began, America’s View On Manufacturing Has Changed
For decades, manufacturing was a loaded word. But manufacturing is America’s comeback story. And in these divided times, it ...
Apple: Billions of dollars in manufacturing site investment will create 'thousands' of AI-related jobs
Tech giant Apple says it will build a new manufacturing facility in Texas at some point in 2026 which will create "thousands" ...
Crain's Detroit23h
Detroit Manufacturing Systems to acquire pair of competitors to create powerhouse auto supplier
Smith on Wednesday signed a deal — subject to regulatory approvals — to acquire metro Detroit-based Android Industries LLC ...
The Challenges Of 2025: A Practical Guide For Manufacturing Leaders
With global trade policies growing increasingly unpredictable, manufacturing businesses face the prospect of significant ...
Lilly expands US manufacturing build-out with $50B target
The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...
Buffalo News21h
How Buffalo’s Manufacturing Industry is Thriving in the Age of AI
Buffalo’s manufacturing industry, which has long been a staple of the local economy, is finding new opportunities through AI ...
Eli Lilly to Build 4 New Factories. Why That’s More Important Than the Cost.
Eli Lilly is building four new manufacturing sites, the drug company announced Wednesday, and though the $27 billion price ...